Latest News on XRAY

Financial News Based On Company


Advertisement
Advertisement

Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization

https://www.globenewswire.com/news-release/2025/10/02/3160344/0/en/Dentsply-Sirona-Appoints-Aldo-M-Denti-as-Chief-Commercial-Officer-and-Announces-Customer-Centric-Organization.html
CHARLOTTE, N.C., Oct. 02, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) ( Nasdaq: XRAY ) today announced that Aldo M. Denti has been appointed Executive Vice President and Chief Commercial Officer ( CCO ) , effective October 6, 2025.

Dentsply Sirona Appoints Aldo M. Denti as Chief Commercial Officer and Announces Customer-Centric Organization - Dentsply Sirona ( NASDAQ:XRAY )

https://www.benzinga.com/pressreleases/25/10/g47991469/dentsply-sirona-appoints-aldo-m-denti-as-chief-commercial-officer-and-announces-customer-centric-o
CHARLOTTE, N.C., Oct. 02, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) ( NASDAQ:XRAY ) today announced that Aldo M. Denti has been appointed Executive Vice President and Chief Commercial Officer ( CCO ) , effective October 6, 2025.

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields - GSK ( NYSE:GSK ) , Bristol-Myers Squibb ( NYSE:BMY )

https://www.benzinga.com/trading-ideas/dividends/25/10/47964908/wall-streets-most-accurate-analysts-weigh-in-on-3-health-care-stocks-with-over-4-dividend
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Dentsply Sirona Retains Wellspect Following Strategic Review

https://www.zacks.com/stock/news/2749205/dentsply-sirona-retains-wellspect-following-strategic-review
XRAY will keep its Wellspect unit, betting on its strong cash flows and $2B market to deliver greater long-term shareholder value.

Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives - Dentsply Sirona ( NASDAQ:XRAY )

https://www.benzinga.com/pressreleases/25/09/g47544978/dentsply-sirona-retains-wellspect-healthcare-as-a-portfolio-business-following-comprehensive-revie
CHARLOTTE, N.C., Sept. 08, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) XRAY today announced that the Company has completed the evaluation of strategic alternatives for its Wellspect Healthcare business ( "Wellspect" ) , which was announced in February ...
Advertisement

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 4% Dividend Yields - Pfizer ( NYSE:PFE ) , Bristol-Myers Squibb ( NYSE:BMY )

https://www.benzinga.com/trading-ideas/dividends/25/09/47509147/wall-streets-most-accurate-analysts-spotlight-on-3-health-care-stocks-with-over-4-dividen
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Dentsply Sirona ( XRAY ) Q2 2025 Earnings Transcript

https://www.fool.com/earnings/call-transcripts/2025/09/02/dentsply-sirona-xray-q2-2025-earnings-transcript/
Image source: The Motley Fool.Thursday, August 7, 2025 at 8:30 a.m. ETChief Executive Officer - Daniel T. ScavillaContinue reading ...

Dentsply Sirona Grows Margins Amid Slump

https://www.fool.com/data-news/2025/09/02/dentsply-sirona-grows-margins-amid-slump/
Dentsply Sirona ( NASDAQ:XRAY ) reported Q2 2025 earnings on August 7, 2025, posting net sales of $936 million ( non-GAAP ) , down 4.9% year-over-year and 6.7% in constant currency and adjusted EPS of $0.52 ( up 6.6% YoY ) .

Universadent.com Empowers Dentists with Groundbreaking Comparison of Top Intraoral Scanners for Enhanced Clinical Excellence

https://markets.businessinsider.com/news/stocks/universadent-com-empowers-dentists-with-groundbreaking-comparison-of-top-intraoral-scanners-for-enhanced-clinical-excellence-1035100065
Universadent LLC, a trusted provider of dental technology insights, has released a comprehensive and unbiased comparison of three leading dental intraoral scanners-Medit i900, 3Shape TRIOS 5, and Dentsply Sirona Primescan Connect.

Dentsply Sirona to Participate in Upcoming Investor Conferences

https://www.globenewswire.com/news-release/2025/08/26/3139637/0/en/Dentsply-Sirona-to-Participate-in-Upcoming-Investor-Conferences.html
CHARLOTTE, N.C., Aug. 26, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) ( Nasdaq: XRAY ) today announced its participation at upcoming conferences.
Advertisement

Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand

https://www.zacks.com/stock/news/2742686/cooper-companies-likely-to-beat-q3-earnings-estimate-on-lens-demand
COO's Q3 results may top estimates, powered by strong demand for MyDay lenses, Biofinity gains and surgical product resilience despite fertility softness.

Medtronic makes two key additions to its board. How activist Elliott can build shareholder value

https://www.cnbc.com/2025/08/23/medtronic-makes-two-key-additions-to-its-board-how-activist-elliott-can-build-shareholder-value.html
The stage seems to be set for a long-term mutually beneficial relationship between the parties.

Is the Options Market Predicting a Spike in DENTSPLY Stock?

https://www.zacks.com/stock/news/2740923/is-the-options-market-predicting-a-spike-in-dentsply-stock
Investors need to pay close attention to XRAY stock based on the movements in the options market lately.

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Medtronic ( NYSE:MDT ) , Bristol-Myers Squibb ( NYSE:BMY )

https://www.benzinga.com/trading-ideas/dividends/25/08/47216696/wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-delivering-hi
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Why Dentsply International ( XRAY ) is a Top Growth Stock for the Long-Term

https://www.zacks.com/stock/news/2683971/why-dentsply-international-xray-is-a-top-growth-stock-for-the-long-term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Advertisement

What's Going On With Dentsply Sirona Stock Thursday? - Dentsply Sirona ( NASDAQ:XRAY )

https://www.benzinga.com/markets/earnings/25/08/46975488/dentsply-sirona-maintains-outlook-despite-sales-decline
Adj EPS of $0.52 tops estimates as gross margins expand to 52.4% despite a 4.9% sales decline to $936M. Adjusted EBITDA surged 14.6% to $197M with margin up to 21.1%, even as operating cash flow dipped to $48M. The market's back, and these 3 income stocks are thriving. See them here→

XRAY Stock Rises on Q2 Earnings & Revenues Beat, Adjusted Margins Up

https://www.zacks.com/stock/news/2679151/xray-stock-rises-on-q2-earnings-revenues-beat-adjusted-margins-up
DENTSPLY SIRONA tops Q2 earnings estimates with margin gains, but revenue declines and U.S. weakness persists.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

https://www.zacks.com/stock/news/2678666/why-this-1-value-stock-could-be-a-great-addition-to-your-portfolio
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Dentsply Sirona Reports Second Quarter 2025 Results

https://www.globenewswire.com/news-release/2025/08/07/3128991/0/en/Dentsply-Sirona-Reports-Second-Quarter-2025-Results.html
CHARLOTTE, N.C., Aug. 07, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) ( Nasdaq: XRAY ) today announced its financial results for the second quarter of 2025.

Should Value Investors Buy Dentsply Sirona ( XRAY ) Stock?

https://www.zacks.com/stock/news/2661995/should-value-investors-buy-dentsply-sirona-xray-stock
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Advertisement

DENTSPLY SIRONA to Post Q2 Earnings: What's in Store for the Stock?

https://www.zacks.com/stock/news/2661509/dentsply-sirona-to-post-q2-earnings-whats-in-store-for-the-stock
XRAY's Imaging strength and SureSmile growth might have lifted Q2 performance, but Byte's drag and macro pressures likely clouded the top-line momentum.

Here's Why Dentsply International ( XRAY ) is a Strong Momentum Stock

https://www.zacks.com/stock/news/2628838/heres-why-dentsply-international-xray-is-a-strong-momentum-stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why Dentsply International ( XRAY ) is a Strong Value Stock

https://www.zacks.com/stock/news/2603208/heres-why-dentsply-international-xray-is-a-strong-value-stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer

https://www.globenewswire.com/news-release/2025/07/21/3118712/0/en/Dentsply-Sirona-Appoints-Daniel-Scavilla-as-Chief-Executive-Officer.html
Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook ...

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer - Globus Medical ( NYSE:GMED ) , Dentsply Sirona ( NASDAQ:XRAY )

https://www.benzinga.com/pressreleases/25/07/g46516601/dentsply-sirona-appoints-daniel-scavilla-as-chief-executive-officer
CHARLOTTE, N.C., July 21, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or "the Company" ) XRAY today announced that Daniel Scavilla, an established business leader with more than three decades of experience in the medical technology and pharmaceutical industries and a ...
Advertisement

Are Investors Undervaluing Dentsply Sirona ( XRAY ) Right Now?

https://www.zacks.com/stock/news/2591623/are-investors-undervaluing-dentsply-sirona-xray-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now

https://www.zacks.com/stock/news/2586094/reasons-to-add-dentsply-sirona-stock-to-your-portfolio-now
XRAY gains traction with digital implants, R&D strength, and Q1 margin growth despite softness in Europe.

Braces, Bottlenecks And The Billion-Dollar Fix

https://www.benzinga.com/general/health-care/25/07/46420240/braces-bottlenecks-and-the-billion-dollar-fix
SmileDirectClub - once a high-flying DTC ( direct-to-consumer ) orthodontics startup - serves as a cautionary tale for healthcare investors. Founded in 2014, it raised nearly $400 million before its 2019 IPO, where it secured $1.3 billion and reached a valuation of almost $8.9 billion.

Dentsply Sirona to Host Second Quarter Conference Call on August 7th - Dentsply Sirona ( NASDAQ:XRAY )

https://www.benzinga.com/pressreleases/25/07/g46341136/dentsply-sirona-to-host-second-quarter-conference-call-on-august-7th
CHARLOTTE, N.C., July 10, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) XRAY today announced that the Company will host an investor conference call and live webcast on Thursday, August 7, 2025, at 8:30 am ET to review its financial results for the second ...

Why Dentsply International ( XRAY ) is a Top Momentum Stock for the Long-Term

https://www.zacks.com/stock/news/2569112/why-dentsply-international-xray-is-a-top-momentum-stock-for-the-long-term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Advertisement

Is Dentsply Sirona ( XRAY ) Stock Undervalued Right Now?

https://www.zacks.com/stock/news/2560366/is-dentsply-sirona-xray-stock-undervalued-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Arvinas ( NASDAQ:ARVN ) , Merck & Co ( NYSE:MRK )

https://www.benzinga.com/trading-ideas/dividends/25/06/45992687/wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-delivering-hi
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Should Value Investors Buy Dentsply Sirona ( XRAY ) Stock?

https://www.zacks.com/stock/news/2503409/should-value-investors-buy-dentsply-sirona-xray-stock
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is the Options Market Predicting a Spike in Dentsply Sirona Stock?

https://www.zacks.com/stock/news/2496035/is-the-options-market-predicting-a-spike-in-dentsply-sirona-stock
Investors need to pay close attention to XRAY stock based on the movements in the options market lately.

Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now

https://www.zacks.com/stock/news/2494478/reasons-to-add-dentsply-sirona-stock-to-your-portfolio-now
XRAY continues to gain traction from a robust product portfolio. However, the macroeconomic factors, such as weakened global demand, persist.
Advertisement

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes

https://www.globenewswire.com/news-release/2025/06/05/3094832/0/en/Dentsply-Sirona-Prices-Offering-of-550-million-of-Junior-Subordinated-Notes.html
CHARLOTTE, N.C., June 05, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) ( Nasdaq: XRAY ) today announced it has priced an offering ( the "Offering" ) of $550 million aggregate principal amount of its 8.375% Junior Subordinated Notes due 2055 ( the "notes" ...

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes - Dentsply Sirona ( NASDAQ:XRAY )

https://www.benzinga.com/pressreleases/25/06/g45805011/dentsply-sirona-prices-offering-of-550-million-of-junior-subordinated-notes
CHARLOTTE, N.C., June 05, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) XRAY today announced it has priced an offering ( the "Offering" ) of $550 million aggregate principal amount of its 8.375% Junior Subordinated Notes due 2055 ( the "notes" ) .

Are Investors Undervaluing Dentsply Sirona ( XRAY ) Right Now?

https://www.zacks.com/stock/news/2479481/are-investors-undervaluing-dentsply-sirona-xray-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Top 4 Value Stocks With Impressive PEG Ratios to Buy Now

https://www.zacks.com/stock/news/2479465/top-4-value-stocks-with-impressive-peg-ratios-to-buy-now
Here are the four discounted PEG-based value stocks that qualify our screening criteria- URBN, XRAY, LTM and EXEL.

Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer

https://www.globenewswire.com/news-release/2025/05/29/3090739/0/en/Dentsply-Sirona-Appoints-Matthew-E-Garth-as-Chief-Financial-Officer.html
CHARLOTTE, N.C., May 29, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) ( Nasdaq: XRAY ) today announced that Matthew E. Garth has been appointed Executive Vice President and Chief Financial Officer, effective May 30, 2025.
Advertisement

Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer - Minerals Technologies ( NYSE:MTX ) , Scotts Miracle Gro ( NYSE:SMG )

https://www.benzinga.com/pressreleases/25/05/g45681872/dentsply-sirona-appoints-matthew-e-garth-as-chief-financial-officer
CHARLOTTE, N.C., May 29, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) XRAY today announced that Matthew E. Garth has been appointed Executive Vice President and Chief Financial Officer, effective May 30, 2025.

Dentsply Sirona Declares Quarterly Cash Dividend

https://www.globenewswire.com/news-release/2025/05/27/3089016/0/en/Dentsply-Sirona-Declares-Quarterly-Cash-Dividend.html
CHARLOTTE, N.C., May 27, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) ( Nasdaq: XRAY ) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share.

Dentsply Sirona Declares Quarterly Cash Dividend - Dentsply Sirona ( NASDAQ:XRAY )

https://www.benzinga.com/pressreleases/25/05/g45630800/dentsply-sirona-declares-quarterly-cash-dividend
CHARLOTTE, N.C., May 27, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) XRAY announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share.

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Merck & Co ( NYSE:MRK ) , Pfizer ( NYSE:PFE )

https://www.benzinga.com/analyst-ratings/price-target/25/05/45562627/wall-streets-most-accurate-analysts-give-their-take-on-3-health-care-stocks-deliveri
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Cooper Companies Q2 Earnings Likely to Reflect Seasonal Trends

https://www.zacks.com/stock/news/2474488/cooper-companies-q2-earnings-likely-to-reflect-seasonal-trends
COO's fiscal second-quarter results are expected to follow seasonal trends, with a lighter start compared to the previous two reported quarters.
Advertisement

Dentsply Sirona to Participate in the 2025 Stifel Jaws & Paws Conference

https://www.globenewswire.com/news-release/2025/05/19/3083873/0/en/Dentsply-Sirona-to-Participate-in-the-2025-Stifel-Jaws-Paws-Conference.html
CHARLOTTE, N.C., May 19, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) ( Nasdaq: XRAY ) today announced that the Company will participate in the 2025 Stifel Jaws & Paws Conference. Management is scheduled to present on Wednesday, May 28, 2025, at 9:45 am ...

Dentsply Sirona to Participate in the 2025 Stifel Jaws & Paws Conference - Dentsply Sirona ( NASDAQ:XRAY )

https://www.benzinga.com/pressreleases/25/05/g45489792/dentsply-sirona-to-participate-in-the-2025-stifel-jaws-paws-conference
CHARLOTTE, N.C., May 19, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or the "Company" ) XRAY today announced that the Company will participate in the 2025 Stifel Jaws & Paws Conference. Management is scheduled to present on Wednesday, May 28, 2025, at 9:45 am ET.

Nutanix Announces Updates to its Board of Directors - Nutanix ( NASDAQ:NTNX )

https://www.benzinga.com/pressreleases/25/05/g45466488/nutanix-announces-updates-to-its-board-of-directors
New Board Member Eric K. Brandt Brings Extensive Leadership and Finance Experience to Nutanix Board David Humphrey Resigns from Nutanix Board SAN JOSE, Calif., May 16, 2025 ( GLOBE NEWSWIRE ) -- Nutanix NTNX, a leader in hybrid multicloud computing, announced today that it has added Eric K.

Is Dentsply Sirona ( XRAY ) Stock Undervalued Right Now?

https://www.zacks.com/stock/news/2470384/is-dentsply-sirona-xray-stock-undervalued-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday - Medicus Pharma ( NASDAQ:MDCX ) , Marriott International ( NASDAQ:MAR )

https://www.benzinga.com/25/05/45348276/marriott-international-to-rally-more-than-17-here-are-10-top-analyst-forecasts-for-monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Guggenheim cut Intellia Therapeutics, Inc. NTLA price target from $55 to $45.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement